Owlet (OWLT) Income from Continuing Operations (2020 - 2026)
Owlet (OWLT) reported Income from Continuing Operations of 3336000.0 for Q1 2026, down 210.28% year-over-year from 3025000.0 in Q1 2025, and up 63.7% quarter-over-quarter from 9190000.0 in Q4 2025.
Owlet (OWLT) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Income from Continuing Operations data on file, last reported at 3336000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 3336000.0, down 210.28% year-over-year; the trailing twelve-month figure through Mar 2026 was 46039000.0 (down 260.1% YoY), and the FY2025 annual result was 39678000.0, down 216.51% from the prior year.
- Income from Continuing Operations improved to 3336000.0 in Q1 2026 per OWLT's latest filing, from 9190000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 4134000.0 in Q3 2025 and troughed at 37647000.0 in Q2 2025.
- A 5-year average of 9869823.53 and a median of 8467000.0 in 2023 frame the typical range for Income from Continuing Operations.
- On a YoY basis, Income from Continuing Operations climbed as much as 173.68% in 2025 and fell as far as 3182.21% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 19498000.0 in 2022, then surged by 64.48% to 6926000.0 in 2023, then plunged by 30.7% to 9052000.0 in 2024, then slipped by 1.52% to 9190000.0 in 2025, then soared by 63.7% to 3336000.0 in 2026.
- Business Quant data shows OWLT's Income from Continuing Operations at 3336000.0 in Q1 2026, 9190000.0 in Q4 2025, and 4134000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Owlet | 136.53 Mn | 95.52 Mn | 12.24 Mn | -3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.34 Mn |
| Dec 31, 2025 | -9.19 Mn |
| Sep 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | -37.65 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | -9.05 Mn |
| Sep 30, 2024 | -5.61 Mn |
| Jun 30, 2024 | -1.15 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | -6.93 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Jun 30, 2023 | -8.47 Mn |
| Mar 31, 2023 | -11.87 Mn |
| Dec 31, 2022 | -19.50 Mn |
| Sep 30, 2022 | -19.36 Mn |
| Jun 30, 2022 | -11.72 Mn |
| Mar 31, 2022 | -28.76 Mn |
| Dec 31, 2021 | -24.06 Mn |
| Sep 30, 2021 | -34.46 Mn |
| Jun 30, 2021 | -5.34 Mn |